(1)
A Retrospective Analysis to Estimate Trough Concentrations of Teicoplanin in Patients With Suspected or Documented Gram-Positive Infections. Braz. J. Pharm. Sci. 2023, 59, e21077. https://doi.org/10.1590/s2175-97902023e21077.